Randomized controlled studies evaluating topiramate, botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: a systematic review and meta-analysis - Giri, S; Tronvik, E; Linde, M (Cephalalgia, 2023)
et al.